HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gondi Kumar Selected Research
Gondi Kumar Research Topics
Disease
3
Multiple Myeloma
12/2022 - 04/2014
3
Neoplasms (Cancer)
12/2022 - 09/2006
3
Pain (Aches)
06/2011 - 09/2008
3
Inflammation (Inflammations)
06/2011 - 04/2006
2
Congenital Abnormalities (Deformity)
12/2022 - 10/2018
2
Body Weight (Weight, Body)
12/2022 - 09/2006
2
Chronic Pain
09/2008 - 04/2006
1
Fetal Weight
12/2022
1
Multiple Sclerosis
01/2021
1
Ectromelia (Phocomelia)
10/2018
1
Fetal Diseases (Embryopathy)
10/2018
1
Prostatic Neoplasms (Prostate Cancer)
01/2016
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2014
1
Breast Neoplasms (Breast Cancer)
04/2014
1
Psoriasis (Pustulosis Palmaris et Plantaris)
12/2011
1
Psoriatic Arthritis
12/2011
1
Chronic Kidney Failure (Chronic Renal Failure)
12/2007
Drug/Important Bio-Agent (IBA)
4
Lenalidomide (CC 5013)
FDA Link
12/2022 - 12/2007
2
Thalidomide (Thalomid)
FDA Link
12/2022 - 10/2018
2
Bradykinin B1 Receptor Antagonists
IBA
06/2011 - 09/2008
2
Bradykinin B1 Receptor
IBA
08/2010 - 05/2007
1
ozanimod
IBA
01/2021
1
enzalutamide
IBA
01/2016
1
Bortezomib (Velcade)
FDA Link
02/2015
1
pomalidomide
IBA
02/2015
1
Peptides (Polypeptides)
IBA
04/2014
1
Subfamily B ATP Binding Cassette Transporter
IBA
04/2014
1
Cations
IBA
04/2014
1
multidrug resistance-associated protein 1
IBA
04/2014
1
Anions
IBA
04/2014
1
Proteins (Proteins, Gene)
FDA Link
04/2014
1
Organic Anion Transporters
IBA
04/2014
1
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
04/2014
1
apremilast
IBA
12/2011
1
Acetamides
IBA
06/2011
1
Sulfones
IBA
09/2008
1
3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazole
IBA
09/2008
1
motesanib diphosphate
IBA
09/2006
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
09/2006
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
09/2006
1
Platelet-Derived Growth Factor
IBA
09/2006
1
Bradykinin
IBA
04/2006
Therapy/Procedure
2
Therapeutics
10/2018 - 01/2016